“showed a trend”

A multivariate analysis in which these CpG sites were examined conjointly showed a trend for the overall multivariate effect (F(2,20) = 2.61, p = 0.098, partial η 2 = 0.21).

The compulsive factor showed a trend‐level association ( R 2 = 0.82%, p = 0.098, Figure 3a ).

The 2M-DOX group showed a trend toward decreased myeloperoxidase ( p = 0.098) expression in comparison to the 2M-Control group (Fig. 5 F).

Kaplan-Meier analysis showed a trend for higher 3-year OS (89.1% vs. 67.5%; p = 0.098) and DFS (70.0% vs. 52.6%; p = 0.138) for the patients in the Responders’ group, although the differences failed for significance (Fig. 1 ).

With regard to cortical microstructural measures, regression models showed a trend toward a positive relationship between lower cortical f is , particularly of normal‐appearing cortex, and worse cognition [ Β (95% CI) = 0.17 (−0.03; 0.37), p = 0.098; Fig.

Intestinal Morphology Intestinal morphology analysis ( Figure 1 A–D) revealed that DEX stimulation significantly reduced villus height in the duodenum and jejunum of 67-day-old broilers ( p < 0.05) and showed a trend towards reducing villus height in the ileum ( p = 0.098).

The ADFI was similar ( P > 0.05) between treatments; however, pigs fed amoxicillin showed a trend ( P = 0.098) to have a poorer feed conversion efficiency for the entire study compared to the other treatments ( Table 8 ).

Patients with higher diversity showed a trend toward lower gut aGVHD (11.1% ± 4.7% [SE] vs 24.4% ± 6.4% [SE]; P = .098), whereas no differences were found between the groups in terms of BSI (23.8% ± 6.6% [SE] vs 20.9% ± 6.2% [SE]; P = .735) and TRM (8.9% ± 4.2% [SE] vs 15.6% ± 6.2% [SE]; P = .473; supplemental Figure 4 ).

YAC128 mice treated with 50 μg HTT ASO showed a trend toward increased plasma NfL compared to PBS at each time point over the 3-month interval, which was highest at 1-month post-treatment ( P = 0.098).

These adjusted models showed a trend toward a treatment effect for ADAS-cog (P = 0.098) and indicated significantly less HV loss for tramiprosate 100 mg (P = 0.035) and 150 mg (P = 0.009) compared to placebo.

Baseline values showed a trend to a significant difference between groups in FES-I ( p = 0.098 trend) and no significant difference in GDS ( p = 0.104).

4B ), and the ranked amplitude of abductor hallucis MEPs showed a trend ( b = 0.0011, CI: −0.0002, 0.0024, P = 0.098, marginal R 2 = 0.04).

The final model performed similarly to the less expansive model without CMMSE with similar variance (R2=13.4% in both models), with no significant influence conferred by cognitive performance and immune-endocrine profile, while MTA score showed a trend towards increased odds for baseline physical frailty (OR=1.72, 95% C.I 0.90-3.25, p=0.098).

During the same period the NYD showed a trend of increase from 18% to 35% (OR = 1.10 [95% CI 0.98-1.23] p = 0.098).

Among microstructural variables, a statistically significant difference was observed for app.BS/BV ( p = 0.032) and app.BV/TV showed a trend ( p = 0.098), both in favor of teriparatide ( Table 3 , Fig. 4 ).

Coinfected patients with advanced hepatic fibrosis (F2–F4) showed a trend towards reduced α-diversity compared with patients with mild hepatic fibrosis (F0–F1) (p = 0.098–p = 0.078, data not shown).

Propionic acid showed a trend to respond in a quadratic fashion, reaching an estimated maximum at 68% PS ( P = 0.098).

Celastrol administration showed a trend towards decreasing the IL-10 production induced by the whey hydrolysate with a DH of 6% ( p = 0.098).

For MI, the regression of the spline coefficient showed a trend for significance ( P =0.098) and for improvement of goodness of fit ( P =0.12).

Furthermore SNORD113.6 showed a small but significant correlation with total leukocytes (B = 0.012, p = 0.026), whereas SNORD113.2 showed a trend towards an inverse correlation with total leukocytes (B = −0.746, p = 0.098).

Furthermore, downregulation of miR-34a in GC samples predicted poorer outcome in overall survival ( P = 0.024) [ 36 ], but for recurrence free survival, decreased miR-34a only showed a trend to correlate with poor prognosis ( P = 0.098, Fig. 6c and Additional file 7 : Table S6).

Respiratory complications showed a trend toward reduction (19.0% vs. 29.0%, p = 0.098).

In comparison with MYC control, SU cells with stable expression of HOXA9 showed a trend for more sphere formation ( p = 0.098, t -test, Supplementary Fig.

Of note, high tCD103 TILs and tFoxP3 TILs density showed a trend of better DFS in TNBC cases (χ 2 = 2.735, P = .098 and χ 2 = 3.555, P = .059, respectively; Supplementary Figs. 3–4 ).

The PFS showed a trend toward a better PFS for patients treated with an intended dose of 9 g/m 2 ( p = .098; Fig. 2 B).